Product correctly added to cart.

discount label
14-Bromo Daunorubicin Hydrobromide Salt (>75%)
View 3D

TRC logo

14-Bromo Daunorubicin Hydrobromide Salt (>75%)

CAS: 60873-68-9

Ref. TR-B682790

5mg
320.00 €
50mg
2,106.00 €
Estimated delivery in United States, on Tuesday 21 May 2024

Product Information

Name:
14-Bromo Daunorubicin Hydrobromide Salt (>75%)
Controlled Product
Synonyms:
  • (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromoacetyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrobromide
  • 14-Bromodaunomycin Hydrobromide Salt
Description:

Stability Hygroscopic
Applications Adriamycin analogue; used as anticancer agent.
References Krishan, A., et al.: Cancer Res., 41, 2745 (1981), Mueller, M., et al.: Eur. J. Biochem., 140, 447 (1984),

Brand:
TRC
Long term storage:
Notes:

Chemical properties

Molecular weight:
687.33
Formula:
C27H28BrNO10•HBr
Purity:
>75%
Color/Form:
Red to Very Dark Red Solid
InChI:
InChI=1S/C27H28BrNO10.BrH/c1-10-22(31)13(29)6-17(38-10)39-15-8-27(36,16(30)9-28)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,31,33,35-36H,6-9,29H2,1-2H3;1H/t10-,13+,15-,17-,22+,27-;/m0./s1
InChI key:
InChIKey=MYLSQMUXMDHPTM-MKDHCJGYSA-N
SMILES:
Br.COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CBr)C[C@@H]3O[C@H]1C[C@@H](N)[C@H](O)[C@H](C)O1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TR-B682790 14-Bromo Daunorubicin Hydrobromide Salt (>75%)

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".